Bringing pharmaceutical weed to telehealth, medical cannabis company Vitura Health (ASX: VIT) has decided to acquire telehealth company Doctors on Demand for an aggregate consideration of $25 million. This deal includes an upfront cash payment, a deferred cash component, and an equity stake. The acquisition marks Vitura’s leap into new healthcare verticals, including urgent care,
Read MoreParenting is no cakewalk. Over 30% of new Aussie parents worry about their child developing an internet addiction. What’s more, they find parenting all the more challenging if their child has complex issues. Melbourne-based medical device company TALi Digital (ASX: TD1) provides parents with virtual games, like Ready, Attention, Go (which won a Red Dot
Read MoreAccording to the US Food and Drug Administration (FDA), Precision Medicine, or “personalised medicine”, is a new way of tailoring disease care by considering people’s unique genes, environments, and lifestyles. The goal is to give the right treatments at the right time.
Read MoreTraditionally, underwriting for health insurance involves conducting blood tests and other examinations to understand how much insurers can afford. However, this process tends to be slow and costly, thus needing a better alternative. That’s where digital healthcare company Advanced Health Intelligence (ASX: AHI) comes in. The Company has entered a Letter of Intent (LOI) with
Read MoreThe eyes are the windows of the world, but for about one in seven Australians over the age of 50 years, they had no choice but to live with dark, blurry areas in the centre of their vision as a result of a condition called age-related Macular Degeneration (AMD). Being the second leading cause of
Read MoreIt has not taken long for private enquiry firms to circle Healthia (ASX: HLA), Australia fastest growing physiotherapy and podiatry operator which has received an offer to be 100% acquired for $260 million. The binding Scheme Implementation Deed comes from Harold BidCo, an entity owned by funds advised by Pacific Equity Partners (PEP) at $1.80
Read MoreThe content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.